[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Editorial Board::
Executive Members::
Articles Archive::
Instruction to Authors::
Peer-Review::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 9, Issue 1 (3-2007) ::
J Gorgan Univ Med Sci 2007, 9(1): 14-19 Back to browse issues page
Elevated plasma copper/zinc ratios in patients with schizophrenia
Farzin D * 1, Mansouri N , Yazdani T , Ebrahimi P , Zargami M , Azari P , Hosseini H
Abstract:   (19806 Views)
Background&Objective: Copper and zinc, two essential trace elements, are neuroactive substances that can be synaptically released during neuronal activity. These metals have been implicated in diseases with neuropathological components, including Alzheimer's disease, Menkes disease, Wilson's disease, Pick's disease, stroke and seizures. Copper and zinc levels in body tissues reflect many physiological and pathological conditions, including dietary factors, hepatic disease, and acute and chronic infections. The purpose of the present study was to examine the plasma levels of copper (Cu) and zinc (Zn) in schizophrenic patients and to compare the Cu/Zn ratios with that of matched healthy subjects. Materials&Methods: Forty patients with schizophrenia (diagnosis were made according to DSM-IV) were sampled along with 50 healthy controls. Exclusion criteria included another concurrent psychiatric disorder, pregnancy, and medical disorders (endocrine, immune, liver cirrhosis, renal) or drugs (anticonvulsants, contraceptives, glucocorticoids) known to affect trace element metabolism. Fasting blood samples were withdrawn from an antecubital vein between 07.00 and 09.00 h. Plasma copper and zinc levels were measured using an atomic absorption spectrophotometer (Perkin Elmer GmbH, Uebelingen, Germany). Two-tailed t test was used to determine statistical differences. All data were analyzed with the computer program, GRAPHPAD software (V2.01+). Results: Mean±SE of sera copper levels in cases and controls were 145±28 and 65±3 µg/dl respectively (P<0.05). Also Mean±SE of sera zinc level in cases and controls were 67±2 and 81±4 µg/dl, respectively (P<0.05). Cu/Zn ratios was 2.07±0.38 and 0.87±0.04 in cases and controls respectively (P<0.05). Conclusion: There was a significant higher Cu/Zn ratio in schizophrenic patients compared to healthy subjects. These results suggest that Cu and Zn may be involved in the pathophysiology of schizophrenia.
Keywords: Atomic absorption, Copper, Zinc, Schizophrenia
Full-Text [PDF 248 kb] [English Abstract]   (15163 Downloads)    
Type of Study: Original Articles |
* Corresponding Author Address: davoodfarzin@yahoo.com


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

D F, N M, T Y, P E, M Z, P A et al . Elevated plasma copper/zinc ratios in patients with schizophrenia. J Gorgan Univ Med Sci 2007; 9 (1) :14-19
URL: http://goums.ac.ir/journal/article-1-270-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 9, Issue 1 (3-2007) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 35 queries by YEKTAWEB 4657